binge eating semaglutide Weight Loss in Patients With Disorder Randomly Assigned to Make Selection:Single Bottle 2025Q3 TrimRX | Ozempic and

binge eating semaglutide Weight Loss in Patients With Disorder Randomly Assigned to Make Selection:Single Bottle 2025Q3 TrimRX | Ozempic and

TrimRX | Ozempic and Heartburn: Managing Acid Reflux on GLP-1

After first use, the pen can stay at room temperature (up to 30°C / 86°F) for 56 days because the preservative (phenol) prevents microbial growth, and the buffer still has enough capacity for short-term stability

2025Q3

Make Selection:Single Bottle

🤓Very convincing data and reassuring data in weight reduction and CV risk factors improvement👍 🤓Overall, less CV events than expected 🤓No significant difference in MACE-5 or MACE-3 but this was relatively small trial with only 1949 participants 🤓Confirmation of CV safety but larger CV trials will be needed to further explore protection against major cardiovascular event #retatrutide #obesity #CVevents #MACE #weightreduction #diabetes #lipids #bloodpressure #TRIUMP3trial Martin Haluzík’s Post ❗𝐓𝐨𝐩𝐥𝐢𝐧𝐞 𝐝𝐚𝐭𝐚 𝐟𝐨𝐫 𝐓𝐑𝐈𝐔𝐌𝐏𝐇-3 𝐩𝐡𝐚𝐬𝐞 3 𝐭𝐫𝐢𝐚𝐥 𝐰𝐢𝐭𝐡 𝐫𝐞𝐭𝐚𝐭𝐫𝐮𝐭𝐢𝐝𝐞 𝐢𝐧 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐬𝐞𝐯𝐞𝐫𝐞 𝐨𝐛𝐞𝐬𝐢𝐭𝐲 𝐚𝐧𝐝 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐰𝐢𝐭𝐡 𝐨𝐫 𝐰𝐢𝐭𝐡𝐨𝐮𝐭 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐣𝐮𝐬𝐭 𝐫𝐞𝐥𝐞𝐚𝐬𝐞𝐝 𝐛𝐲 𝐄𝐥𝐢 𝐋𝐢𝐥𝐥𝐲❗ ✍In TRIUMPH-3, both studied doses of retatrutide (9 mg and 12 mg) delivered substantial weight loss in adults with severe obesity and established cardiovascular disease, with or without type 2 diabetes